HCA Healthcare remains a soft buy with improving fundamentals and strong buyback plans despite recent stock weakness.
HCA Healthcare is still considered a soft buy despite recent stock underperformance, as its revenue and profitability continue to grow driven by Medicare/Medicaid and higher admissions revenue. The company is shrinking its physical footprint but main...
